Moderna COVID-19 vaccine trial in kids ages 12 to 17 hits full enrollment
February 27 2021, 08:00
Moderna has completed enrollment for a Phase 2/3 study of its COVID-19 vaccine in adolescents ages 12 to 17.
Moderna has completed enrollment for a Phase 2/3 study of its COVID-19 vaccine in adolescents ages 12 to 17.
Source:
FOX News